Comparison Between RunX2 and Osteocalcin Expression Following the Application of Demineralized Freeze-Dried Bone Xenograft (DBFX) and Bovine Hydroxyapatite (BHA) and Their Effect on Bone Defect (In vivo Laboratory Experiment)

Ikhram Kharis
{"title":"Comparison Between RunX2 and Osteocalcin Expression Following the Application of Demineralized Freeze-Dried Bone Xenograft (DBFX) and Bovine Hydroxyapatite (BHA) and Their Effect on Bone Defect (In vivo Laboratory Experiment)","authors":"Ikhram Kharis","doi":"10.20473/jscrte.v5i2.33145","DOIUrl":null,"url":null,"abstract":"The use of biomaterial such as bone graft material is highly needed in oral and maxillofacial surgery to overcome bone defect that happened due to various reasons. One of the bone graft that widely used is bovine hydroxyapatite (BHA). BHA is produced by means of deproteinizing by a high-temperature heating process so that inorganic material of bone is left where the bone architecture is preserved. This material has osteoconductive property because it induces osteoblast activity and new bone formation. DFDBX is a bone graft derived from bovine bone which has undergone the demineralization process and subsequently frozen. Then, it will be exposed to hydrochloric acid until the bone matrix component-related collagen fibril called BMPs. Runt-Related Transcription factor 2 (RUNX2) is a transcription factor which is needed for osteoblast differentiation and it is first detected at preosteoblast. Osteocalcin is exerted during the last stage of differentiation, started at the early stage of mineralization. Objectives to compare the expression of RUNX2 and Osteocalcin following the application of DFDBX and BHA to the bone defect. Methode 30 male New Zealand White Rabbit, 6- months old, 3-3,5kg, divided into 3 groups comprising of 10 animals each, bone defect is created on each animal model. On group 1, DFDBX is applicated, BHA is on group 2, and control group with no graft application. After 2 weeks and 4 weeks following the animal model is terminated to retrieve a bone specimens for Immunohystochemistry examination. Result The expression of RUNX2 following the application of DFDBX and BHA showed a significant difference at week 2 but not showed at week 4. This research also found that the expression of osteocalcin did not show a significant difference at week 2 but showed a significant difference at week 4. Conclussion This study demonstrate that bone healing process in DFDBX group is more effective than BHA.","PeriodicalId":17049,"journal":{"name":"Journal of Stem Cell Research and Tissue Engineering","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stem Cell Research and Tissue Engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20473/jscrte.v5i2.33145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The use of biomaterial such as bone graft material is highly needed in oral and maxillofacial surgery to overcome bone defect that happened due to various reasons. One of the bone graft that widely used is bovine hydroxyapatite (BHA). BHA is produced by means of deproteinizing by a high-temperature heating process so that inorganic material of bone is left where the bone architecture is preserved. This material has osteoconductive property because it induces osteoblast activity and new bone formation. DFDBX is a bone graft derived from bovine bone which has undergone the demineralization process and subsequently frozen. Then, it will be exposed to hydrochloric acid until the bone matrix component-related collagen fibril called BMPs. Runt-Related Transcription factor 2 (RUNX2) is a transcription factor which is needed for osteoblast differentiation and it is first detected at preosteoblast. Osteocalcin is exerted during the last stage of differentiation, started at the early stage of mineralization. Objectives to compare the expression of RUNX2 and Osteocalcin following the application of DFDBX and BHA to the bone defect. Methode 30 male New Zealand White Rabbit, 6- months old, 3-3,5kg, divided into 3 groups comprising of 10 animals each, bone defect is created on each animal model. On group 1, DFDBX is applicated, BHA is on group 2, and control group with no graft application. After 2 weeks and 4 weeks following the animal model is terminated to retrieve a bone specimens for Immunohystochemistry examination. Result The expression of RUNX2 following the application of DFDBX and BHA showed a significant difference at week 2 but not showed at week 4. This research also found that the expression of osteocalcin did not show a significant difference at week 2 but showed a significant difference at week 4. Conclussion This study demonstrate that bone healing process in DFDBX group is more effective than BHA.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脱矿冻干异种骨移植(DBFX)与牛羟基磷灰石(BHA)应用后RunX2和骨钙素表达的比较及其对骨缺损的影响(体内实验)
在口腔颌面外科手术中,为了克服各种原因导致的骨缺损,迫切需要使用骨移植材料等生物材料。牛羟基磷灰石(BHA)是目前广泛应用的骨移植材料之一。BHA是通过高温加热过程脱蛋白的方式生产的,这样骨骼的无机物质就留在了骨骼结构被保存的地方。这种材料具有骨导电性,因为它能诱导成骨细胞活性和新骨形成。DFDBX是一种从牛骨中提取的骨移植物,经过脱矿过程并随后冷冻。然后,将其暴露在盐酸中,直到与骨基质成分相关的胶原纤维称为bmp。runt相关转录因子2 (RUNX2)是成骨细胞分化所需的转录因子,最早在成骨细胞前被检测到。骨钙素在分化的最后阶段发挥作用,开始于矿化的早期阶段。目的比较DFDBX和BHA治疗骨缺损后RUNX2和骨钙素的表达。方法选用6月龄、3 ~ 3岁、5kg的雄性新西兰大白兔30只,随机分为3组,每组10只,造骨缺损。1组应用DFDBX, 2组应用BHA,对照组不应用移植物。分别于2周和4周后终止动物模型取骨标本进行免疫化学检查。结果应用DFDBX和BHA后,RUNX2的表达在第2周有显著差异,而在第4周无显著差异。本研究还发现骨钙素的表达在第2周无显著差异,但在第4周有显著差异。结论DFDBX组骨愈合过程明显优于BHA组。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
PROFILE OF NUTRITIONAL STATUS, HEMOGLOBIN, LEUKOCYTES, PLATELET, HEMATOCRIT, ALBUMIN AND SEROLOGY TEST IN CHILDREN INFECTED WITH DENGUE VIRUS AT DR SOETOMO HOSPITAL YEAR 2015 CYTOTOXICITY TEST OF BOVINE DEMINERALIZED BONE MATRIX ON HUMAN MESENCHYMAL STEM CELLS USING THE MTT ASSAY METHOD INCREASE MIGRATION OF PERIPHERAL BLOOD DERIVED ENDOTHELIAL PROGENITOR CELLS OF STABLE CORONARY ARTERY DISEASE PATIENT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS THE EFFECT OF PLATELET-RICH PLASMA ADMINISTRATION ON PROLIFERATION AND DIFFERENTIATION OF ENDOTHELIAL PROGENITOR CELLS IN PATIENTS WITH STABLE CORONARY HEART DISEASE CHONDROREGENERATIVE POTENTIAL ON SUBCUTANEOUS IMPLANTATION OF PLATELET-RICH FIBRIN (PRF)-IMPREGNATED DECELLULARIZED BOVINE CARTILAGE SCAFFOLD
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1